Pennsylvania | 000-00121 | 23-1498399 | ||||||||||||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common Stock, Without Par Value | KLIC | The Nasdaq Global Market |
Item 9.01 |
Financial Statements and Exhibits. |
|||||||
(d) | Exhibits. | |||||||
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Inline XBRL for the cover page of this Current Report on Form 8‑K. | |||||||
KULICKE AND SOFFA INDUSTRIES, INC. | |||||||||||
Date: August 7, 2024 | By: | /s/ LESTER WONG | |||||||||
Name: | Lester Wong | ||||||||||
Title: | Executive Vice President and Chief Financial Officer (principal financial officer and principal accounting officer) |
||||||||||
![]() |
Kulicke & Soffa Pte. Ltd.
23A Serangoon North Ave 5
Singapore 554369
+65 6880-9600 main
Co. Regn. No. 199902120H
|
||||
Kulicke and Soffa Industries, Inc.
1005 Virginia Drive
Fort Washington, PA 19034 USA
+1-215-784-6000 main
www.kns.com
|
Quarterly Results - U.S. GAAP | |||||||||||
Fiscal Q3 2024
|
Change vs.
Fiscal Q3 2023
|
Change vs.
Fiscal Q2 2024
|
|||||||||
Net Revenue | $181.7 million | down 4.9% | up 5.6% | ||||||||
Gross Margin | 46.6% | down 60 bps | up 3700 bps | ||||||||
Income from Operations | $8.3 million | up 284.4% | up 107.9% | ||||||||
Operating Margin | 4.6% | up 700 bps | up 6570 bps | ||||||||
Net Income | $12.3 million | up 194.7% | up 111.9% | ||||||||
Net Margin | 6.8% | up 460 bps | up 6650 bps | ||||||||
EPS – Diluted | $0.22 | up 214.3% | up 112% |
Quarterly Results - Non-GAAP | |||||||||||
Fiscal Q3 2024
|
Change vs.
Fiscal Q3 2023
|
Change vs.
Fiscal Q2 2024
|
|||||||||
Income from Operations | $15.9 million | down 34.6% | up 131.7% | ||||||||
Operating Margin | 8.7% | down 400 bps | up 3790 bps | ||||||||
Net Income | $19.3 million | down 39.4% | down 136.3% | ||||||||
Net Margin | 10.6% | down 610 bps | up 4150 bps | ||||||||
EPS – Diluted | $0.35 | down 36.4% | down 136.8% |
Kulicke and Soffa Industries, Inc. | |||||
Joseph Elgindy | |||||
Finance | |||||
P: +1-215-784-7518 | |||||
Three months ended | Nine months ended | ||||||||||||||||||||||
June 29, 2024 | July 1, 2023 | June 29, 2024 | July 1, 2023 | ||||||||||||||||||||
Net revenue | $ | 181,650 | $ | 190,917 | $ | 524,913 | $ | 540,171 | |||||||||||||||
Cost of sales | 96,920 | 100,899 | 343,816 | 277,355 | |||||||||||||||||||
Gross profit | 84,730 | 90,018 | 181,097 | 262,816 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Selling, general and administrative | 37,266 | 34,550 | 112,497 | 108,113 | |||||||||||||||||||
Research and development | 37,937 | 36,578 | 112,451 | 107,085 | |||||||||||||||||||
Impairment charges | — | 21,535 | 44,472 | 21,535 | |||||||||||||||||||
Amortization of intangible assets | 1,250 | 1,786 | 3,922 | 4,743 | |||||||||||||||||||
Acquisition-related costs | — | 57 | — | 498 | |||||||||||||||||||
Restructuring | — | — | 2,940 | 879 | |||||||||||||||||||
Total operating expenses | 76,453 | 94,506 | 276,282 | 242,853 | |||||||||||||||||||
Income / (loss) from operations | 8,277 | (4,488) | (95,185) | 19,963 | |||||||||||||||||||
Other income (expense): | |||||||||||||||||||||||
Interest income | 8,060 | 8,847 | 26,807 | 23,406 | |||||||||||||||||||
Interest expense | (20) | (50) | (60) | (116) | |||||||||||||||||||
Income / (loss) before income taxes | 16,317 | 4,309 | (68,438) | 43,253 | |||||||||||||||||||
Income tax expense | 4,053 | 148 | 12,685 | 9,462 | |||||||||||||||||||
Net income / (loss) | $ | 12,264 | $ | 4,161 | $ | (81,123) | $ | 33,791 | |||||||||||||||
Net income / (loss) per share: | |||||||||||||||||||||||
Basic | $ | 0.22 | $ | 0.07 | $ | (1.45) | $ | 0.60 | |||||||||||||||
Diluted | $ | 0.22 | $ | 0.07 | $ | (1.45) | $ | 0.59 | |||||||||||||||
Cash dividends declared per share | $ | 0.20 | $ | 0.19 | $ | 0.60 | $ | 0.57 | |||||||||||||||
Weighted average shares outstanding: | |||||||||||||||||||||||
Basic | 55,280 | 56,553 | 56,028 | 56,763 | |||||||||||||||||||
Diluted | 55,724 | 57,519 | 56,028 | 57,684 |
Three months ended | Nine months ended | ||||||||||||||||||||||
Supplemental financial data: | June 29, 2024 | July 1, 2023 | June 29, 2024 | July 1, 2023 | |||||||||||||||||||
Depreciation and amortization | $ | 4,944 | $ | 8,591 | $ | 19,896 | $ | 20,746 | |||||||||||||||
Capital expenditures | 3,266 | 10,451 | 10,645 | 43,485 | |||||||||||||||||||
Equity-based compensation expense: | |||||||||||||||||||||||
Cost of sales | 315 | 272 | 1,037 | 903 | |||||||||||||||||||
Selling, general and administrative | 4,300 | 3,800 | 14,083 | 12,398 | |||||||||||||||||||
Research and development | 1,748 | 1,331 | 5,332 | 4,002 | |||||||||||||||||||
Total equity-based compensation expense | $ | 6,363 | $ | 5,403 | $ | 20,452 | $ | 17,303 |
As of | |||||||||||
June 29, 2024 | July 1, 2023 | ||||||||||
Number of employees | 2,790 | 3,045 |
As of | |||||||||||
June 29, 2024 | September 30, 2023 | ||||||||||
ASSETS | |||||||||||
CURRENT ASSETS | |||||||||||
Cash and cash equivalents | $ | 366,917 | $ | 529,402 | |||||||
Short-term investments |
235,000 | 230,000 | |||||||||
Accounts and other receivable, net of allowance for doubtful accounts of $49 and $49, respectively | 200,320 | 158,601 | |||||||||
Inventories, net | 175,551 | 217,304 | |||||||||
Prepaid expenses and other current assets | 35,300 | 53,751 | |||||||||
TOTAL CURRENT ASSETS | 1,013,088 | 1,189,058 | |||||||||
Property, plant and equipment, net | 64,536 | 110,051 | |||||||||
Operating right-of-use assets | 35,875 | 47,148 | |||||||||
Goodwill | 88,933 | 88,673 | |||||||||
Intangible assets, net | 25,744 | 29,357 | |||||||||
Deferred tax assets |
16,983 | 31,551 | |||||||||
Equity investments |
2,900 | 716 | |||||||||
Other assets | 9,156 | 3,223 | |||||||||
TOTAL ASSETS | $ | 1,257,215 | $ | 1,499,777 | |||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||
CURRENT LIABILITIES | |||||||||||
Accounts payable | 52,145 | 49,302 | |||||||||
Operating lease liabilities | 7,128 | 6,574 | |||||||||
Accrued expenses and other current liabilities | 89,979 | 103,005 | |||||||||
Income taxes payable | 16,725 | 22,670 | |||||||||
TOTAL CURRENT LIABILITIES | 165,977 | 181,551 | |||||||||
Deferred tax liabilities | 35,705 | 37,264 | |||||||||
Income taxes payable | 35,639 | 52,793 | |||||||||
Operating lease liabilities | 32,524 | 41,839 | |||||||||
Other liabilities | 13,832 | 11,769 | |||||||||
TOTAL LIABILITIES | 283,677 | 325,216 | |||||||||
SHAREHOLDERS' EQUITY | |||||||||||
Common stock, no par value | 590,915 | 577,727 | |||||||||
Treasury stock, at cost | (838,803) | (737,214) | |||||||||
Retained earnings | 1,241,235 | 1,355,810 | |||||||||
Accumulated other comprehensive loss | (19,809) | (21,762) | |||||||||
TOTAL SHAREHOLDERS' EQUITY | $ | 973,538 | $ | 1,174,561 | |||||||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ | 1,257,215 | $ | 1,499,777 |
Three months ended | Nine months ended | ||||||||||||||||||||||
June 29, 2024 | July 1, 2023 | June 29, 2024 | July 1, 2023 | ||||||||||||||||||||
Net cash provided by / (used in) operating activities | $ | 26,897 | $ | 8,976 | $ | (582) | $ | 95,912 | |||||||||||||||
Net cash provided by / (used in) investing activities | 36,594 | 24,473 | (20,518) | (161,724) | |||||||||||||||||||
Net cash used in financing activities | (55,933) | (19,447) | (141,729) | (92,358) | |||||||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | (389) | (1,298) | 344 | 4,439 | |||||||||||||||||||
Changes in cash and cash equivalents | 7,169 | 12,704 | (162,485) | (153,731) | |||||||||||||||||||
Cash and cash equivalents, beginning of period | 359,748 | 389,102 | 529,402 | 555,537 | |||||||||||||||||||
Cash and cash equivalents, end of period | $ | 366,917 | $ | 401,806 | $ | 366,917 | $ | 401,806 | |||||||||||||||
Short-term investments | 235,000 | 310,000 | 235,000 | 310,000 | |||||||||||||||||||
Total cash, cash equivalents and short-term investments | $ | 601,917 | $ | 711,806 | $ | 601,917 | $ | 711,806 | |||||||||||||||
Three months ended | ||||||||||||||||||||
June 29, 2024 | July 1, 2023 | March 30, 2024 | ||||||||||||||||||
Net revenue | $ | 181,650 | $ | 190,917 | $ | 172,074 | ||||||||||||||
U.S. GAAP income from operations | 8,277 | (4,488) | (105,155) | |||||||||||||||||
U.S. GAAP operating margin | 4.6 | % | (2.4) | % | (61.1) | % | ||||||||||||||
Pre-tax non-GAAP items: | ||||||||||||||||||||
Amortization related to intangible assets | 1,250 | 1,786 | 1,325 | |||||||||||||||||
Restructuring and severance | — | — | 2,940 | |||||||||||||||||
Equity-based compensation | 6,363 | 5,403 | 6,232 | |||||||||||||||||
Impairment charges | — | 21,535 | 44,472 | |||||||||||||||||
Acquisition-related costs |
— | 57 | — | |||||||||||||||||
Non-GAAP income from operations | $ | 15,890 | $ | 24,293 | $ | (50,186) | ||||||||||||||
Non-GAAP operating margin | 8.7 | % | 12.7 | % | (29.2) | % | ||||||||||||||
Three months ended | ||||||||||||||||||||
June 29, 2024 | July 1, 2023 | March 30, 2024 | ||||||||||||||||||
Net revenue | $ | 181,650 | $ | 190,917 | $ | 172,074 | ||||||||||||||
U.S. GAAP net income / (loss) | 12,264 | 4,161 | (102,680) | |||||||||||||||||
U.S. GAAP net margin | 6.8 | % | 2.2 | % | (59.7) | % | ||||||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||
Amortization related to intangible assets | 1,250 | 1,786 | 1,325 | |||||||||||||||||
Restructuring and severance | — | — | 2,940 | |||||||||||||||||
Equity-based compensation | 6,363 | 5,403 | 6,232 | |||||||||||||||||
Impairment charges | — | 21,535 | 44,472 | |||||||||||||||||
Acquisition-related costs | — | 57 | — | |||||||||||||||||
Net income tax benefit on non-GAAP items |
(568) | (1,060) | (5,534) | |||||||||||||||||
Total non-GAAP adjustments | $ | 7,045 | $ | 27,721 | $ | 49,435 | ||||||||||||||
Non-GAAP net income / (loss) | $ | 19,309 | $ | 31,882 | $ | (53,245) | ||||||||||||||
Non-GAAP net margin | 10.6 | % | 16.7 | % | (30.9) | % | ||||||||||||||
U.S. GAAP net income / (loss) per share: | ||||||||||||||||||||
Basic | 0.22 | 0.07 | (1.83) | |||||||||||||||||
Diluted(a) |
0.22 | 0.07 | (1.83) | |||||||||||||||||
Non-GAAP adjustments per share:(b) |
||||||||||||||||||||
Basic | 0.13 | 0.49 | 0.88 | |||||||||||||||||
Diluted | 0.13 | 0.48 | 0.88 | |||||||||||||||||
Non-GAAP net income / (loss) per share: | ||||||||||||||||||||
Basic | $ | 0.35 | $ | 0.56 | $ | (0.95) | ||||||||||||||
Diluted(c) |
$ | 0.35 | $ | 0.55 | $ | (0.95) | ||||||||||||||
Weighted average shares outstanding: | ||||||||||||||||||||
Basic | 55,280 | 56,553 | 56,154 | |||||||||||||||||
Diluted | 55,724 | 57,519 | 56,154 | |||||||||||||||||
Three months ended | ||||||||||||||||||||
June 29, 2024 | July 1, 2023 | March 30, 2024 | ||||||||||||||||||
U.S. GAAP net cash provided by / (used in) by operating activities | $ | 26,897 | $ | 8,976 | $ | (20,148) | ||||||||||||||
Expenditures for property, plant and equipment | (2,683) | (10,610) | (6,571) | |||||||||||||||||
Proceeds from sales of property, plant and equipment | — | 83 | — | |||||||||||||||||
Non-GAAP adjusted free cash flow | 24,214 | (1,551) | (26,719) | |||||||||||||||||
Fourth quarter of fiscal 2024 ending September 28, 2024 |
||||||||||||||||||||
GAAP Outlook | Adjustments | Non-GAAP Outlook | ||||||||||||||||||
Net revenue |
$180 million
+/- $10 million
|
— |
$180 million
+/- $10 million
|
|||||||||||||||||
Operating expenses |
$76.5 million
+/- 2%
|
$7.5 million B,C |
$69.0 million
+/- 2%
|
|||||||||||||||||
Diluted EPS(1) |
$0.22
+/- 10%
|
$0.13 A, B, C,D |
$0.35
+/- 10%
|
|||||||||||||||||
Non-GAAP Adjustments | ||||||||||||||||||||
A. Equity-based compensation - Cost of sales |
0.3 | |||||||||||||||||||
B. Equity-based compensation - Selling, general and administrative and Research and development | 6.3 | |||||||||||||||||||
C. Amortization related to intangible assets |
1.2 | |||||||||||||||||||
D. Net income tax effect of the above items |
(0.6) | |||||||||||||||||||